Electrocortical and Biochemical Evaluation of Antidepressant Efficacy of Formulated Nanocurcumin
- PMID: 30167967
- DOI: 10.1007/s12010-018-2866-4
Electrocortical and Biochemical Evaluation of Antidepressant Efficacy of Formulated Nanocurcumin
Abstract
The present study aims to evaluate the antidepressant efficacy of curcumin nanoparticles on rat model of depression induced by reserpine. Rats were divided into control, the rat model of depression induced by daily i.p. injection of reserpine (0.2 mg/kg for 21 days), and the rat model of depression treated daily with the formulated CNPs (20 mg/kg for 7 and 15 days). The behavioral evaluation was assessed for all groups of animals by the forced swim test (FST). Monoamine neurotransmitters were measured in the cortex and hippocampus via fluorescence spectroscopy. The electrophysiological evaluation was carried out by recording and analyzing the electrocorticogram (ECoG) in a group of animals that served as self-control. The chronic administration of reserpine resulted in a significant decrease in the duration of the active phase in the FST; a significant decrease in the cortical and hippocampal levels of serotonin, norepinephrine, and dopamine; a significant increase in spectral power of alpha and delta waves; and a significant decrease in spectral power of theta, beta-1, and beta-2 waves with respect to control values. Administration of CNPs for 7 days has improved the performance of animals in FST indicated by the increase in the duration of the active phase. Additionally, the levels of serotonin and dopamine have been restored; however, the level of norepinephrine has been not completely recovered in both cortex and hippocampus. A significant increase in alpha and beta-2 waves, an increase in theta and beta-1, and a decrease in delta waves have been recorded after 7 days of treatment. Extending treatment with CNPs for 15 days has succeeded in restoring the active phase in FST and monoamine level in the cortex and hippocampus to control like values. In addition, ECoG waves have returned to near control like values. It could be concluded that the formulated nanocurcumin has an effective and potent antidepressant activity that was evidenced by electrical, chemical, and behavioral tests.
Keywords: Curcumin nanoparticles; Electrocorticogram; FST; Fluorescence; Monoamiones; Rat.
Similar articles
-
Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression.Eur J Pharmacol. 2021 Oct 5;908:174384. doi: 10.1016/j.ejphar.2021.174384. Epub 2021 Jul 27. Eur J Pharmacol. 2021. PMID: 34324858
-
Evaluation of the Therapeutic Effect of Curcumin-Conjugated Zinc Oxide Nanoparticles on Reserpine-Induced Depression in Wistar Rats.Biol Trace Elem Res. 2024 Jun;202(6):2630-2644. doi: 10.1007/s12011-023-03849-z. Epub 2023 Sep 15. Biol Trace Elem Res. 2024. PMID: 37713054 Free PMC article.
-
Antidepressant activity of curcumin: involvement of serotonin and dopamine system.Psychopharmacology (Berl). 2008 Dec;201(3):435-42. doi: 10.1007/s00213-008-1300-y. Epub 2008 Sep 3. Psychopharmacology (Berl). 2008. PMID: 18766332
-
On the mechanism of antidepressant-like action of berberine chloride.Eur J Pharmacol. 2008 Jul 28;589(1-3):163-72. doi: 10.1016/j.ejphar.2008.05.043. Epub 2008 Jun 3. Eur J Pharmacol. 2008. PMID: 18585703
-
Analysis of main constituents and mechanisms underlying antidepressant-like effects of Xiaochaihutang in mice.J Ethnopharmacol. 2015 Dec 4;175:48-57. doi: 10.1016/j.jep.2015.08.031. Epub 2015 Aug 28. J Ethnopharmacol. 2015. PMID: 26318746
Cited by
-
Dietary Supplementations and Depression.J Multidiscip Healthc. 2022 May 17;15:1121-1141. doi: 10.2147/JMDH.S360029. eCollection 2022. J Multidiscip Healthc. 2022. PMID: 35607362 Free PMC article. Review.
-
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence-A Narrative Review.Front Psychiatry. 2020 Nov 27;11:572533. doi: 10.3389/fpsyt.2020.572533. eCollection 2020. Front Psychiatry. 2020. PMID: 33329109 Free PMC article. Review.
-
A comprehensive review on the impact of polyphenol supplementation and exercise on depression and brain function parameters.Behav Brain Funct. 2025 Mar 26;21(1):10. doi: 10.1186/s12993-025-00273-2. Behav Brain Funct. 2025. PMID: 40140839 Free PMC article. Review.
-
An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders.Antioxidants (Basel). 2022 Feb 10;11(2):353. doi: 10.3390/antiox11020353. Antioxidants (Basel). 2022. PMID: 35204235 Free PMC article. Review.
-
A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin.Front Pharmacol. 2022 Mar 25;13:820806. doi: 10.3389/fphar.2022.820806. eCollection 2022. Front Pharmacol. 2022. PMID: 35401176 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous